Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Bex

Showing results (161-170 of 332) with videos related to

Pageof 34
Sort By:
Cancers|October 26, 2024
A National Study of the Rate of Benign Pathology After Partial Nephrectomy for T1 Renal Cell Carcinoma: Should We Be Satisfied?Luna van den Brink, Tess Debelle, Lieke Gietelink, et al.
Current Problems in Cancer|June 16, 2021
High-risk Surgically Resected Renal Cell Carcinoma: Is There a Role for Adjuvant VEGF-TKI Inhibitors?Giuseppe Fallara, Marco Bandini, Alessandro Larcher, et al.
BJU International|December 30, 2021
'Case of the Month' from the Specialist Centre for Kidney Cancer, Royal Free London Hospital, UK: <sup>99m</sup> Tc-sestamibi SPECT-CT to differentiate renal cell carcinoma from benign oncocytomaJonjo Miller, Nicholas Campain, Anna-Rita Boydell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2008
Sunitinib for treatment of advanced renal cell cancer: primary tumor responseAstrid A M van der Veldt, Martijn R Meijerink, Alfons J M van den Eertwegh, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 28, 2016
Toward (Hybrid) Navigation of a Fluorescence Camera in an Open Surgery SettingGijs H KleinJan, Nynke S van den Berg, Matthias N van Oosterom, et al.
World Journal of Urology|May 7, 2020
Additional surgical procedures and perioperative morbidity in post-chemotherapy retroperitoneal lymph node dissection for metastatic testicular cancer in two intermediate volume hospitalsJoost M Blok, Richard P Meijer, Henk G van der Poel, et al.
World Journal of Urology|May 3, 2022
Surgical margins after partial nephrectomy as prognostic factor for the risk of local recurrence in pT1 RCC: a systematic review and narrative synthesisMichaël M E L Henderickx, Suraj V Baldew, Lorenzo Marconi, et al.
Cancers|March 11, 2023
MRI Characteristics of Pediatric and Young-Adult Renal Cell Carcinoma: A Single-Center Retrospective Study and Literature ReviewJustine N van der Beek, Ronald R de Krijger, Rutger A J Nievelstein, et al.
European Urology Focus|October 14, 2022
Comparison of Long-term Outcomes for Young and Healthy Patients with cT1a and cT3a Renal Cell Carcinoma Treated with Partial NephrectomyWei Shen Tan, Mara Koelker, Nicholas Campain, et al.
European Urology Oncology|January 21, 2020
Deferred Cytoreductive Nephrectomy Following Presurgical Vascular Endothelial Growth Factor Receptor-targeted Therapy in Patients with Primary Metastatic Clear Cell Renal Cell Carcinoma: A Pooled Analysis of Prospective Trial DataRoderick de Bruijn, Akhila Wimalasingham, Bernadett Szabados, et al.
Pageof 34

Showing results (161-170 of 332) with videos related to

Sort By:
Pageof 34
Cancers|October 26, 2024
A National Study of the Rate of Benign Pathology After Partial Nephrectomy for T1 Renal Cell Carcinoma: Should We Be Satisfied?Luna van den Brink, Tess Debelle, Lieke Gietelink, et al.
Current Problems in Cancer|June 16, 2021
High-risk Surgically Resected Renal Cell Carcinoma: Is There a Role for Adjuvant VEGF-TKI Inhibitors?Giuseppe Fallara, Marco Bandini, Alessandro Larcher, et al.
BJU International|December 30, 2021
'Case of the Month' from the Specialist Centre for Kidney Cancer, Royal Free London Hospital, UK: <sup>99m</sup> Tc-sestamibi SPECT-CT to differentiate renal cell carcinoma from benign oncocytomaJonjo Miller, Nicholas Campain, Anna-Rita Boydell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2008
Sunitinib for treatment of advanced renal cell cancer: primary tumor responseAstrid A M van der Veldt, Martijn R Meijerink, Alfons J M van den Eertwegh, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 28, 2016
Toward (Hybrid) Navigation of a Fluorescence Camera in an Open Surgery SettingGijs H KleinJan, Nynke S van den Berg, Matthias N van Oosterom, et al.
World Journal of Urology|May 7, 2020
Additional surgical procedures and perioperative morbidity in post-chemotherapy retroperitoneal lymph node dissection for metastatic testicular cancer in two intermediate volume hospitalsJoost M Blok, Richard P Meijer, Henk G van der Poel, et al.
World Journal of Urology|May 3, 2022
Surgical margins after partial nephrectomy as prognostic factor for the risk of local recurrence in pT1 RCC: a systematic review and narrative synthesisMichaël M E L Henderickx, Suraj V Baldew, Lorenzo Marconi, et al.
Cancers|March 11, 2023
MRI Characteristics of Pediatric and Young-Adult Renal Cell Carcinoma: A Single-Center Retrospective Study and Literature ReviewJustine N van der Beek, Ronald R de Krijger, Rutger A J Nievelstein, et al.
European Urology Focus|October 14, 2022
Comparison of Long-term Outcomes for Young and Healthy Patients with cT1a and cT3a Renal Cell Carcinoma Treated with Partial NephrectomyWei Shen Tan, Mara Koelker, Nicholas Campain, et al.
European Urology Oncology|January 21, 2020
Deferred Cytoreductive Nephrectomy Following Presurgical Vascular Endothelial Growth Factor Receptor-targeted Therapy in Patients with Primary Metastatic Clear Cell Renal Cell Carcinoma: A Pooled Analysis of Prospective Trial DataRoderick de Bruijn, Akhila Wimalasingham, Bernadett Szabados, et al.
Pageof 34